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ABSTRACT 
The differentiation of human pluripotent stem cells (hPSCs) towards the hepatocyte lineage can 
potentially provide an unlimited source of functional hepatocytes for transplantation and 
extracorporeal bioartificial liver applications. It is anticipated that the quantities of cells needed 
for these applications will be in the order of 10
9
-10
10
 cells, because of the size of the liver. An 
ideal differentiation protocol would be to enable directed differentiation to the hepatocyte lineage 
with simultaneous cell expansion. We introduced a cell expansion stage after the commitment of 
human embryonic stem cells (hESCs) to the endodermal lineage, to allow for at least an eight-
fold increase in cell number, with continuation of cell maturation towards the hepatocyte lineage. 
The progressive changes in the transcriptome was measured by expression array and the 
expression dynamics of certain lineage markers was measured by mass cytometry during the 
differentiation and expansion process. The findings revealed that while cells were expanding 
they were also capable of progressing in their differentiation towards the hepatocyte lineage. In 
addition, our transcriptome, protein and functional studies, including albumin secretion, drug-
induced CYP450 expression and urea production, all indicated that the hepatocyte-like cells 
obtained with or without cell expansion are very similar. This method of simultaneous cell 
expansion and hepatocyte differentiation should facilitate obtaining large quantities of cells for 
liver cell applications. 
KEYWORDS:  EMBRYONIC STEM CELLS, GENOMICS, DIFFERENTIATION, GENE EXPRESSION, 
HEPATIC 
 
 Page 2 of 64
St
em
 C
el
ls 
an
d 
D
ev
el
op
m
en
t
Ce
ll 
Ex
pa
ns
io
n 
D
ur
in
g 
D
ire
ct
ed
 D
iff
er
en
tia
tio
n 
O
f S
te
m
 C
el
ls 
To
w
ar
d 
Th
e 
H
ep
at
ic
 L
in
ea
ge
 (d
oi:
 10
.10
89
/sc
d.2
01
6.0
11
9)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
3 
3 
 
S
te
m
 C
el
ls
 a
n
d
 D
ev
el
o
p
m
en
t 
C
el
l 
E
x
p
an
si
o
n
 D
u
ri
n
g
 D
ir
ec
te
d
 D
if
fe
re
n
ti
at
io
n
 O
f 
S
te
m
 C
el
ls
 T
o
w
ar
d
 T
h
e 
H
ep
at
ic
 L
in
ea
g
e
 (
d
o
i:
 1
0
.1
0
8
9
/s
cd
.2
0
1
6
.0
1
1
9
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
INTRODUCTION 
Hepatocytes differentiated from embryonic and induced pluripotent stem cells have the potential 
of becoming an inexhaustible source of hepatocytes for liver cellular therapies and tissue 
engineering applications. Stem cell-derived hepatocytes may also be used in bioartificial liver 
devices to support acute liver failure and drug toxicity screening [1-3]. Over the past decade, 
several protocols have been established to guide the differentiation of pluripotent stem cells 
(PSCs) towards the hepatocyte lineage using sequential cocktails of cytokines and growth factors 
based on our understanding of molecular signals that drive liver development [4-8]. The resulting 
hepatocyte-like cells (HLCs) express many of the hepatocyte transcripts and exhibit several 
hepatocyte functions that mimic those of primary hepatocytes [4-9].  
 
One major challenge for future clinical translation of stem cell-derived hepatocytes is to generate 
a sufficient quantity of cells. Any therapeutic application would require 10
9
-10
10 
hepatic cells per 
treatment [10]. To derive HLCs currently, stem cells are expanded to the required quantity before 
undergoing differentiation towards the hepatocyte lineage. An alternative strategy to circumvent 
this issue would be to not only expand stem cells in their pluripotent state, but also devise a 
methodology to expand PSC-derived progeny during their differentiation towards hepatocytes. 
We hypothesized that with the appropriate signaling cues, it may be possible to expand the 
number of cells during the process of in vitro hepatocyte differentiation by mimicking the native 
proliferation that occurs naturally in vivo.  
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There have been multiple reports on selective surface markers that could be used for isolation of 
renewable hepatocyte progenitor cells [11-13]. In one study, hepatocyte progenitor cells were 
enriched using the surface markers EpCAM or N-cadherin, and subsequently expanded on 
stromal feeder layers [13]. In addition, a self-renewing endodermal cell line was reported where 
CXCR4
+
/CD117
+ 
cells were sorted and expanded on mouse embryonic feeders [14].  
 
To date, there has not been a report of simultaneous in vitro proliferation and differentiation of 
PSC-progeny, just like in vivo fetal liver development. During liver development, cells can 
undergo extensive proliferation using the signaling cues from their surrounding environment to 
increase the liver mass. The formation of the endodermal germ layer is among the first 
differentiation events to occur during mammalian liver development. During gastrulation, 
signaling through the NODAL protein, a member of the TGFβ family, establishes the distinction 
between the endoderm and mesoderm germ layers [15,16]. In murine development, the liver 
along with the lung, pancreas, and stomach are derived from the endoderm around embryonic 
day E9 of gestation [17,18]. During that period, NODAL protein activates several key 
transcription factors including Foxa2 and Sox17, that help regulate cell fate commitment to the 
different endodermal cell lineages [16]. Further signaling cues from the adjacent mesoderm layer 
are responsible for inducing liver development through fibroblast growth factor (FGF) and bone 
morphogenetic protein (BMP) signaling pathways [19]. During this stage, hepatocyte progenitor 
cells arise and proliferate significantly to form the liver bud. Using this knowledge, we attempted 
to incorporate these native signaling cues to induce further proliferation of differentiating 
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hepatocyte precursor cells to generate larger numbers of HLCs from the same PSC starting cell 
number.  
 
In this study, we used growth factor cues to stimulate the native proliferative capacity of 
definitive endoderm cells while they are differentiating towards the hepatic lineage.  We further 
used a multi-parametric single cell analysis tool [20-22] to examine certain lineage markers to 
demonstrate that differentiation and proliferation occurred simultaneously in most if not all cells 
during this process. Using expression arrays and functional studies, we were able to demonstrate 
that the HLCs generated from expanding definitive endodermal cells were similar to those 
obtained using the conventional differentiation protocol without the expansion process.  
 
MATERIALS AND METHODS  
HUMAN EMBRYONIC STEM CELL CULTURE 
The human embryonic stem cell (hESC) line H9 was cultured as described previously [4] using 
80% Knockout™ Dulbecco’s modified Eagle medium (DMEM) (Gibco/BRL), supplemented 
with 20% Knockout Serum Replacement (Gibco, USA), 2.0 mM glutamine, 1X nonessential 
amino acids (Gibco, USA), 55 µM -mercaptoethanol and basic fibroblast growth factor (FGF2, 
R&D) (10 ng/mL). The cells were cultured on irradiated E13-E14 CF-1 mouse embryonic 
fibroblasts (MEFs) (Charles River Laboratories, Wilmington, MA), at 37°C in 10% CO2. The 
cells were passaged on a regular basis every 2-3 days using 0.1% (w/v) Collagenase Type IV 
(Gibco) in Knockout™ DMEM after reaching ~50-70% confluency. 
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HEPATOCYTE DIFFERENTIATION 
H9 cells were plated in 12 well plates coated with 2% Matrigel® (BD Biosciences) in mTESR™ 
medium (Stem Cell Technologies) for 24 hours or until confluency was reached. Differentiation 
was initiated by switching to differentiation medium consisting of a 60/40 (v/v) mixture of low 
glucose Dulbecco’s Modified Eagle media (DMEM) (Gibco, USA) and MCDB-201 (Sigma), 
supplemented with 26 g/mL ascorbic acid 3-phosphate (Sigma), linoleic acid and bovine serum 
albumin (LA-BSA, Sigma) (0.25 mg/mL BSA and 2.35 g/mL linoleic acid), insulin-transferrin-
selenium (ITS, Sigma) (2.5 g/mL insulin, 1.38 g/mL transferrin, 1.25 ng/mL sodium selenite), 
0.4 g/mL dexamethasone (Sigma), 4.3 g/mL -mercaptoethanol (Hyclone), 100 IU/mL 
penicillin and 100 g/ml streptomycin (Gibco, USA) . 2% fetal bovine serum was added to the 
media (v/v) in Stage I for the first six days and 0.5 % (v/v) for the remaining period.  
 
The differentiation medium was supplemented with stage specific growth factors: Stage 1, 
Activin A (100 ng/ml) and Wnt3a (50 ng/ml); Stage 2, FGF2 (10 ng/ml) and BMP4 (50 ng/ml); 
Stage 3, FGF8b (25 ng/ml), FGF1 (50 ng/ml) and FGF4 (10 ng/ml); Stage 4, HGF (20 ng/ml) 
and Follistatin (100 ng/ml) (Figure 1a). Differentiations were carried out at 21% O2 and 5% CO2 
with a 50% media change every 2 days during differentiation. A complete media change was 
performed when changing the stages of differentiation (i.e. day 6, 10, and 14).  
 
For endodermal cell expansion, cells were harvested on Day 6 after the initiation of hepatocyte 
differentiation using 0.1% (w/v) Collagenase Type IV (Gibco) in Knockout DMEM and plated 
onto Matrigel® pre-coated plates in Stage 2 medium containing FGF2 (10 ng/ml) and BMP4 (50 
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ng/ml). A day after plating, the media was completely replenished with Stage 2 medium to 
remove any unattached cells.  On the 3
rd
 day after plating, the cells were passaged again using 
0.1% (w/v) Collagenase Type IV onto Matrigel® coated plates in Stage 2 medium. Three days 
after the second passaging the medium was changed to Stage 3 medium to continue the 
differentiation. 
QUANTITATIVE REAL TIME POLYMERASE CHAIN REACTION (QRT-PCR) 
Total RNA was obtained from cell lysates using the RNAeasy Micro Kit (Qiagen). cDNA was 
synthesized using the Superscript III reverse transcriptase kit (Invitrogen) according to 
manufacturer's instructions. Transcript abundance levels of a sample were normalized to the 
housekeeping gene, GAPDH. Sequences for the primers of the genes used in this study are listed 
in Table S1. For comparison among cells at different stages of differentiation, these values were 
then normalized to hESCs and expressed as log10 (Expression level relative to hESC).  
 
 IMMUNOHISTOCHEMISTRY  
The cells were fixed with 4% paraformaldehyde at room temperature for 20 min, then blocked 
with PBS containing 0.2% Triton-X-100 and 1% donkey serum or BSA (Sigma) at room 
temperature for 1 hr. After blocking, samples were incubated with primary antibodies AFP 
(Dako, 1:1000), ALB (Dako 1:1000), SOX17 (R&D, 1:20), FOXA2 (Abcam, 1:1000) and DAPI 
(Life Technologies, 1:500) overnight at 4 ˚C. The cells were then incubated with secondary 
antibodies (anti-mouse IgG1 Alexa Fluor 488 labeled (Molecular Probes, 1:500 dilution), anti-
rabbit IgG Alexa Fluor 488 (Molecular Probes, 1:500 dilution), or anti-mouse IgG Alexa Fluor 
555 (Molecular Probes, 1:500 dilution)) for 30 min at room temperature. Negative controls were 
cells incubated with only the relevant isotype control and secondary antibody. 
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MASS CYTOMETRY 
Lyophilized antibodies for FOXA2, SOX17, ALB, DLK1, AFP, and AAT proteins were 
obtained from R&D systems. 200 µg of antibodies were conjugated with a selected panel of 
heavy metal isotopes using the MaxPar® antibody labeling kit from Fluidigm according to the 
manufacturer’s instructions with slight modifications. The antibodies were eluted in 50 μl PBS 
instead of W buffer provided by the kit to improve antibody recovery. The conjugated antibodies 
were diluted to 0.5 mg/mL in antibody stabilizer solution (Candor Biosciences, 131050) and 
stored at 4 
o
C until use.  Metal conjugated CXCR4 and CD44 were directly obtained from DVS 
Sciences (Sunnyvale, CA).  
 
Cells were collected with 0.1% collagenase in DMEM and dissociated into single cells using 
trypsin as previously described [5].  About 500,000 cells per sample were fixed using 10 % 
formalin for 20 min at room temperature. The cells were washed with PBS and centrifuged 
before being resuspended in 5 μL Human TruStain FcX™ (BioLegend, 422302) and 95 μL PBS 
at room temperature for 10 min for blocking.  The cells were first incubated in a cocktail of 
metal conjugated antibodies targeting surface markers in 100 µl of PBS for 30 min at room 
temperature. Cells were washed twice with PBS and incubated with a second cocktail of 
antibodies targeting intracellular proteins suspended in 100 µL SAP buffer (PBS with 0.1% 
(w/v) saponin (Sigma, 47036) and 0.05% (w/v) sodium azide (Sigma, 438456)) for 30 min at 
room temperature. After washing twice with SAP buffer, cells were incubated with MaxPar® 
Intercalator-Ir 125 μM (DVS Sciences, 201192A) at a dilution of 1:1000 in 1 mL of SAP buffer 
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overnight at 4°C.  Cells were washed twice, suspended in 500 µL water and passed through a cell 
strainer and analyzed on the CyTOF2 instrument (DVS Sciences). Serially diluted antibodies in 
an antibody cocktail were used to titrate the antibody concentration using hESCs as a negative 
control (Data not shown). Data was analyzed using the Cytobank software (Fluidigm) and 
visualized in Spotfire (Tibco). Data from mass cytometry was visualized and analyzed using a 
flow cytometry experiment data processing software (FlowJo™). A metal-encoded DNA 
intercalator (i.e. Ir191 and Ir193) was used to label nucleated cells [20]. Samples from different 
time points were normalized to each other by assigning the same DNA intercalator median 
intensity value for each sample. Events with very low (intercalator reading <20) or very high 
(intercalator reading > 5000) intensity were removed to exclude cell debris or cell aggregates. 
The filtered events were further analyzed using a spanning-tree progression analysis of density-
normalized events (SPADE) from Cytobank [20,23]. 
 
FUNCTIONAL ANALYSIS OF HLCS  
Albumin was measured using a human specific albumin ELISA kit (Starters Kit Bethyl E101 and 
Bethyl E80-129). Urea was measured using the QuantiChrom Urea Assay Kit (BioAssay 
Systems). Periodic-Acid-Schiff staining (Sigma-Aldrich) was performed according to the 
manufacturer’s protocol. The cells were immersed in Periodic Acid solution for 5 min and in 
Schiff’s reagent for 15 min at room temperature followed by a wash with DI water. To test the 
function of CYP450 enzymes, cells were incubated for 24 hours in differentiation media with or 
without 50 M rifampicin (Gold Biotechnology). The transcript levels of CYP2A6, CYP2C8 and 
CYP2C9, were measured using qRT-PCR.  
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TRANSCRIPTOME ANALYSIS 
Total RNA was extracted from cell samples at various time points of differentiation using the 
RNeasy Mini kit (Qiagen). The transcriptome assay using the Illumina HT12 bead array v3 
(Illumina Inc) was performed by the University of Minnesota Genomic Center (UMGC).   
 
Data was processed using the lumi package in R [24]. Transcriptome data from 34,000 probes 
representing about 20,000 genes was obtained. Principal component analysis (PCA) was 
performed in R. Spotfire (Tibco) and a MATLAB script TimeView were used for data 
visualization and functional analysis [25].         
RESULTS 
EXPANSION OF ENDODERMAL CELLS 
hESCs were differentiated to definitive endoderm (DE) in Stage 1 using a medium containing 
Activin and Wnt3a to reach cell densities of 2.5x10
5
 cells/cm
2
 in six days (D6). The cells were 
then detached by 0.1% collagenase treatment and passaged at ~6 x10
4
 cells/cm
2
 onto Matrigel® 
coated plates in Stage 2 medium containing FGF2 and BMP4 (Figure 1a). Cells adhered to the 
surface a few hours after plating, and expanded up to 3-fold in viable cell number after three 
days (Figure 1b and S1; Endoderm 1, EN1). Cells were then passaged again in Stage 2 medium 
containing FGF2 and BMP4, that have been reported to provide the necessary proliferative cues 
to endodermal cells during embryonic liver development [26]. The endodermal cell population 
expanded approximately 8-fold after two passages as shown in Figure 1b (Endoderm 2, EN2). 
Further passages beyond the second passage were carried out, resulting in cell expansion up to 
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15 fold; however, we detected an increasing population of cells with a fibroblastic morphology 
(Data not shown). By contrast, when we tracked the cell expansion during Stage 2 of the 
conventional differentiation method without passaging, we observed that the cell expansion was 
limited only up to two-fold (Figure 1b). Thus, by implementing two passaging steps during the 
hepatic endoderm commitment stage, we were able to induce an 8-fold expansion by providing 
additional surface area with the signaling cues of Stage 2 medium. 
 
EXPRESSION OF HEPATOCYTE GENES AND PROTEINS IN EXPANDED ENDODERMAL CELLS 
We evaluated the expression of pluripotency, endoderm and hepatic endoderm related genes in 
cells during the expansion by qRT-PCR and immunostaining. Expression of Octamer-binding 
transcription factor 4 (OCT4), a master regulator of the pluripotency network in hESCs [27], 
decreased about 1000 fold during the course of endodermal expansion as expected (Figure 2a). 
The endodermal transcription factor, goosecoid homeobox (GSC), a key marker for 
differentiating definitive and visceral endoderm [28], and CXCR4, a surface marker co-expressed 
with GSC [28], were both highly expressed in the D6 population but decreased in the EN1 and 
EN2 populations. (Figure 2a). Our hypothesis was that similar to in vivo development, ESC-
derived definitive endoderm cells, can proliferate while at the same time differentiate to hepatic 
endoderm. We also evaluated the expression of the genes indicative of maturation to hepatic 
committed endoderm and hepatoblasts. In line with our hypothesis, the decrease in definitive 
endoderm marker gene transcripts was accompanied by almost 1000 fold increase of the 
transcript level of alpha-fetoprotein (AFP) and albumin (ALB) over the expansion period [29]. 
These dynamics of gene expression suggest the gradual transition of an endodermal-committed 
phenotype towards a more hepatic phenotype during the expansion process.  
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We also compared the transcript levels of hepatic endoderm/hepatoblast genes in the EN1 and 
EN2 populations to cells obtained at the end of Stage 2 (D10) and Stage 3 (D14) from the 
conventional differentiation process without cell expansion. Expression levels of OCT4, CXCR4, 
and GSC in EN1 and EN2 cells were similar to those in D10 and D14 cells, respectively (Figure 
2a). Levels of the hepatic transcripts, AFP and ALB, increased more gradually in the 
conventional method of differentiation (D10 and D14), compared to cells undergoing cell 
expansion (Figure 2a).  
 
The transition from an endoderm to a more hepatic stage was also examined by immunostaining 
(Figure 2b and S2). Forkhead Box A2 (FOXA2) and SRY (Sex determining Region Y)-Box 17 
(SOX17), key transcription factors in the establishment of definitive endoderm, were prominent 
in the D6 stage but diminished by the EN2 and D14 stage. In contrast, AFP was absent in the D6 
stage, and became more prominent in both the EN2 and D14 population consistent with the 
transcript levels observed. The results suggest that cells undergoing expansion are differentiating 
simultaneously.  
 
CHARACTERIZATION OF DIFFERENTIATION/EXPANSION PROCESS BY MASS CYTOMETRY 
To identify whether the increase in transcript for hepatic endoderm/hepatoblast marker genes and 
proteins during expansion was restricted to a differentiated subpopulation of cells, or was 
occurring in most of the population, we used mass cytometry to examine co-expression of a 
panel of endodermal and hepatic markers at a single cell resolution [20]. Cells undergoing 
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differentiation were labeled with stable isotopes of lanthanide heavy metal conjugated with 
antibodies against endodermal marker proteins (CXCR4, FOXA2, SOX17) and hepatic marker 
proteins (DLK1, CD44, AFP, ALB and AAT). Similar to flow cytometry, the antibody labelled-
cells were sorted into single cells. But instead of detecting various fluorescent tags, the sorted 
cells are vaporized to leave the stable isotope tags to be analyzed by a time of flight (TOF) mass 
spectrometry. In the TOF analysis, different antibody tags will give sharp and distinctive 
signatures corresponding to its conjugated metal isotope, allowing for quantification of each 
labelled antibody without the need of resolving spectrum spillover or overcoming 
autofluorescence that normally occurs in multiple parametric flow cytometry.  
 
Due to the complexity of the many markers that was used to label a particular cell, 3-D diagrams 
were used to efficiently plot the different marker expression levels. During the course of 
differentiation, various combinations of marker expressions were plotted as 3-D diagrams with 
three markers represented along the X, Y, Z axes and CD44 represented as a color gradient as 
shown in Figures S3 and S4. Still, with such plots it is not easy to gain a global view of the 
evolution of the population during the directed differentiation. Thus, we used the expression 
level of all 8 markers to characterize the co-expression in the different populations using 
Spanning-tree Progression Analysis of Density-normalized Events (SPADE) which groups the 
cells into a defined number of clusters based on its expression pattern [23].  
 
The SPADE analysis utilizes a combined dataset that consists of all the markers’ expression level 
for cells of different differentiation stage during directed differentiation. The dataset was then 
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clustered into 75 nodes based on the expression level of the eight markers for each cell, and the 
clustering results are shown as a tree diagram (Figure S5). Each node constitutes a cluster of 
cells with a similar pattern of expression for all eight markers. Because eight markers are used, 
eight tree diagrams are used to present the results for each marker (Figure S5).  
 
Based on the expression pattern of the different lineage specific markers, certain nodes can then 
be assigned to one of three subpopulations: (A) endodermal cells, (B) hepatic 
endoderm/hepatoblasts, and (C) hepatoblasts/hepatocytes (Figure S5a-h). The designation of the 
different subpopulation is based on the expression pattern of the different markers and is 
described more in detail in the legend of Figure S5. The nodes of the same subpopulation are 
encircled in a dashed line. However, not all nodes were assigned to a subpopulation, especially 
those with low expression levels of most markers.  
 
To validate our classification of the nodes into the different subpopulations, we performed k-
means clustering on the 75 nodes using the median intensity of each marker for each node. The 
vast majority of the nodes for subpopulations A (endodermal cells) and C 
(hepatoblast/hepatocytes) were assigned to its own distinct clusters.  The majority of nodes in 
subpopulation B (hepatic endoderm/hepatoblasts) were mainly scattered across the two clusters 
(Figure S5i). The results of the k-means clustering illustrated that the majority of the nodes 
within a subpopulation were grouped to the same clusters supporting our classification of the 75 
nodes into 3 subpopulations.  
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The mass cytometry data for each stage of differentiation was then mapped to the previously 
made SPADE tree diagram to illustrate the heterogeneity of the different subpopulations within 
each stage. The fraction of cells that were classified to a node for a particular stage will then be 
illustrated by the size and color of the node (Figure 3). Using the fraction of cells for each 
subpopulation, we can then quantitatively determine the heterogeneity at each stage of the 
differentiation/expansion. On D6, 51% of the cells were definitive endodermal cells, expressing 
CXCR4, SOX17, or FOXA2. During the expansion stage (EN1 and EN2) the definitive 
endodermal cells decreased to less than 10% while the early hepatic endoderm/hepatoblasts 
increased steadily to over 50%.  The decrease of definitive endodermal cells and increase of 
hepatic endoderm/hepatoblasts was similar to what we observed in cultures without expansion 
(from D6 to D14).  At the end of the directed differentiation, a similar percentage of hepatocyte-
like cells was obtained with cell expansion (75%) or without (76%). However, considering that 
the cell number had increased significantly at the EN2 stage as compared to D14 of 
differentiation, the total number of hepatocytes obtained is substantially higher with cell 
expansion. 
 
We also used immunostaining of examine key differentiation markers (costaining of AFP and 
ALB, or FOXA2 and SOX17) to confirm the results of mass cytometry measurements. The 
percentage of cells that were positive for those markers were compared to that obtained using 
mass cytometry for different populations (Figure S6). Images of multiple microscopic fields for 
each population sample were randomly taken and the number of all nucleated cells and 
fluorescently stained cells were quantified using CellProfiler [30]. Some differences were 
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observed between the percentage of cells stained and percentage through mass cytometry. 
However, these small differences in percentages between the two approaches were likely caused 
by the chosen threshold values of mass cytometry data classifying positive and negative cells. 
Nevertheless, the overall trend of the dynamics of marker expression was still the same in both 
of the immunostaining and mass cytometry results. 
DIFFERENTIATION POTENTIAL AND FUNCTIONAL ACTIVITY OF EXPANDED ENDODERMAL CELLS 
The results of the mass cytometry studies suggested that the majority of the expanded cells 
(EN2) were capable of differentiating to HLCs. To confirm that HLCs derived with or without 
cell expansion were of the hepatic phenotype, both populations were immunostained and shown 
to be positive for the hepatic marker, ALB (Figure 2c). We evaluated the transcript level of key 
hepatocyte marker genes in D20-HLCs and in EN2-HLCs, including phosphoenolpyruvate 
carboxykinase (PEPCK), alpha-1 antitrypsin (AAT), AFP and ALB. The EN2-HLC population 
expressed all the hepatocyte transcripts levels 10
2
-10
5
 higher compared to hESC, similar to D20-
HLCs (Figure 4a). Transcripts of a number of cytochrome P450 enzymes were also expressed. 
Drug exposure to hepatocytes often induces specific CYP450 enzymes involved in its 
metabolism. Following exposure to rifampicin, we could detect increased transcript levels of its 
corresponding CYP450 enzymes (CYP2C8, CYP2C9 and CYP2A6) in D20-HLCs and EN2-
HLCs (Figure 4b) [31]. The level of increase was comparable between EN2-HLCs and D20-
HLCs. 
 
In addition to drug metabolism, albumin synthesis and urea secretion for both D20-HLC and 
EN2-HLC populations were also measured and shown to be comparable (Figure 4c-d) [5]. 
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Glycogen synthesis was evident in both D20-HLC and EN2-HLC cells as assessed by PAS 
staining (Figure 4e).  
 
COMPARATIVE TRANSCRIPTOME ANALYSIS OF CELLS FROM THE ORIGINAL AND MODIFIED 
PROTOCOL 
The transcriptome of cells at different stages of directed differentiation were evaluated and 
subjected to PCA. The first two principal components (PCs) representing 90% of the variance 
among all samples were chosen to plot all the samples in a two-dimensional PC space as shown 
in Figure 5. ESC, D6, D10, D14 and D20-HLC lined up chronically in order according to their 
differentiation stages, with the least and most mature cells on the two separate ends of the plot. 
EN1, EN2 and D10 cells, all exposed to Stage 2 medium, cluster in a similar region, with EN1 
and EN2 lying between D6 and D10 cells. Both EN2-HLC and D20-HLC co-localize in the same 
region, almost overlapping one another, confirming their similarity in spite of the differences 
with respect to cell expansion.  
 
The gene expression dynamics of cells undergoing directed differentiation from both protocols 
were compared and plotted in groups of similar functional classes (Figures 7 and S7-S8). Overall 
the gene expression profiles show that, regardless of whether or not cells were expanded during 
the endodermal stage, their gene expression dynamics were very similar. The transcript level of 
pluripotent genes POU5F1, NANOG, SOX2, ZIC3, SALL4, and LIN28 decreased from the 
beginning of differentiation as expected (Figure S7). Endodermal genes EOMES, CXCR4, GSC, 
and SOX17 increased in the first stage of differentiation, then decreased in the following stages 
either accompanied by cell expansion or not (Figure 6a). In the presence of Stage 2 medium, a 
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gradual increase in the transcripts of hepatoblast and hepatic genes is seen during the course of 
differentiation, including transcripts for AFP, DLK1, TTR, and KRT8 (hepatoblast specific 
markers) as well as ALB, PEPCK, PCK2, transferrin (TF), α1-antitrypsin (A1AT) (more mature 
hepatocyte markers) (Figure 6b and S8). The expression level of genes pertaining to important 
liver functions such as glycolysis/gluconeogenesis, urea cycle, fatty acid metabolism, and drug 
detoxification were also similar in D20-HLCs and EN2-HLCs (Figure S9). The similarity in 
transcript levels of these genes gives further credence to the notion that although the endodermal 
cells underwent expansion, they retained undiminished differentiation capability to HLCs to a 
degree similar to that of unexpanded endodermal cells. 
 
DISCUSSION 
The differentiation of PSCs towards the hepatocyte lineage raises the possibility of having an 
unlimited supply of human hepatocytes for a number of cellular applications [4,6-8]. Although 
all protocols vary somewhat, they typically consist of treating stem cells with a combination of 
growth factors/cytokines in stages to mimic the key signaling cues occurring during embryonic 
development. However, cellular proliferation, which is integral during in vivo development, is 
typically absent or minimal in directed differentiations of stem cells to hepatocytes. In this study, 
we purposefully introduced cell expansion during the differentiation process between the time of 
commitment to definitive endoderm and the time hepatic endoderm/hepatoblasts are being 
generated, with a goal to not only generate larger quantities of HLCs but also to more accurately 
mimic in vivo development where expansion also occurs.  
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In this study, we demonstrated that hESCs, during the course of hepatocyte differentiation, could 
be expanded at an intermediate endodermal stage and continued to differentiate towards a 
hepatocyte-like phenotype. To mimic the proliferative capability of developing hepatic cells, we 
utilized the soluble factors known to induce endoderm differentiation and promote proliferation 
as a way to incorporate an expansion stage. The factors, BMP4 and FGF2, were chosen to mimic 
the signaling of the cardiogenic mesoderm and septum transversum mesenchyme during the 
transition of the foregut endoderm to the liver bud, a process that involves extensive cell 
migration, proliferation and differentiation [17]. By providing more surface area to cells at the 
intermediate endodermal stage, cells demonstrated the ability to expand up to at least 8-fold. 
Given that we split the cells at a ratio of 1:4 during the first passage, the initial EN population 
showed remarkable proliferative capability within 3 days. By the third passage, up to 15-fold 
increase in cell number was occasionally achieved but the resulting expansion from the third 
passage of cell expansion was not as consistent. In addition, cells with a fibroblastic morphology 
began to emerge when cells were passaged beyond the second expansion stage, suggesting that 
the expanding endodermal cells have a limited proliferative capability similar to developing cells 
in vivo. However, the increase in cell number during the expansion demonstrated that stem cell 
derived endodermal cells exhibit a proliferative capability also seen with endodermal cells in 
developing embryos [17-19]. The expansion in cell number was also accompanied by a 
simultaneous increase in hepatocyte transcript levels along with a drastic decrease in endodermal 
and pluripotent marker gene expression (Figure 2). This finding correlates with what happens to 
developing endodermal cells undergoing proliferation as they commit to the different endoderm 
lineages during liver development [17]. 
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Our results indicated that the definitive endoderm cells were capable of simultaneous 
proliferation and differentiation. However, it is not clear whether the changes in gene expression 
happen to a larger population of cells or to only a small population. We employed mass 
cytometry to examine the progression of cells at different stages of differentiation. The 
population of cells at different stages was further classified into different subpopulations to 
examine the dynamics of the cells during differentiation. In the D6, EN1, EN2, and D14 
populations, only 50-75% of the population were categorized as either endodermal cells, hepatic 
endoderm/hepatoblasts, or hepatoblasts/hepatocytes.  But by the end of the differentiation, the 
percentage of hepatic-committed cells had increased to almost >90%. These results suggest that 
cells differentiate at different rates; giving rise to a heterogeneous population at different stages 
of differentiation. It is noted that a large number of the nodes in the SPADE tree were not 
included as the different classes of differentiated cells. Although the density of cells in each of 
those nodes was small, altogether they constitute a significant fraction of the total cells. It is 
likely that those cells are in a transition stage and also possible that they might include some 
cells that failed to differentiate towards the hepatic lineage. Nevertheless, the majority of the 
population is differentiating along the hepatic lineage. The decrease in endodermal and increase 
in hepatocyte markers occurred in a majority of the cells, as a large fraction of the population co-
expressed multiple hepatocyte markers and lost the expression of early stage markers 
simultaneously. Furthermore, the results demonstrate that the increased hepatic transcript level in 
EN2-HLC was not merely caused by a small subset of cells expressing extremely high levels of 
hepatocyte markers, but was attributed by a majority (>75%) of the cells differentiating towards 
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the hepatic lineage. Moreover, these novel quantitative analyses of the differentiation of 
endodermal cells confirmed that the majority of cells following the expansion process were also 
capable of becoming HLCs. Indeed, the resulting EN2-HLC population was similar to D20-
HLC: both containing a large fraction of cells expressing moderate to high levels of ALB, AFP, 
AAT and CD44, but low levels of endodermal markers. The similarity between EN2-HLC and 
D20-HLC was further confirmed by their ability to secrete albumin, synthesize urea and induce 
cytochrome P450 enzymes in response to rifampicin.  
 
Mass cytometry have been used to explore the heterogeneity in the hematopoietic system and in 
cancer [20,23,32-36]. In stem cell research, it has been used to explore the emergence of induced 
pluripotent stem cells from fibroblasts [37]. In this study, we employed mass cytometry to 
examine the population dynamics during directed differentiation of stem cells toward the hepatic 
lineage. Importantly, we took advantage of the detailed analysis at the single cell level provided 
by mass cytometry by imposing quantitative criteria for each marker to perform quantitative 
analysis of the emergence of different subpopulations at different stages of differentiation. The 
mass cytometry data demonstrate that while endodermal cells underwent expansion, they 
continued on the trajectory of differentiation toward the hepatocyte lineage (Figure 3). This was 
further supported through microarray analyses. Using PCA on the transcriptome data, we plotted 
the results on a PC1 vs. PC2 space to demonstrate the similarities between each sample (Figure 
5). All cell samples lined up in the order of their progression towards the hepatocyte lineage. 
EN1 and EN2 were positioned in between D6 and D10 cells, suggesting that their differentiation 
status is more advanced than D6 but not as mature as D10. Thus, during expansion, endodermal 
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cells were proliferating while also differentiating towards a more hepatic endoderm/hepatoblast 
fate instead of remaining in a renewable endoderm cell stage [14]. 
 
In this study, hESCs were simultaneously expanded while differentiating towards hepatic 
lineage. Other studies have reported the expansion of hepatocyte progenitor cells [12-14].  By 
FACS sorting, EpCAM
+
/c-KIT
-
 hepatic progenitor cells from differentiating mouse ESCs were 
isolated and subsequently expanded on mouse embryonic feeders [12]. In another study, human 
hepatoblasts were sorted from ESC progeny based on N-cadherin expression (14), and 
subsequently cultured as progenitors on stromal feeder cells.  Human endodermal progenitor 
cells have also been clonally isolated from a differentiating population based on expression of 
the surface markers CXCR4 and CD117, and expanded on Matrigel® and feeder cells.  These 
progenitor cells were subsequently differentiated to express hepatic markers. In all three studies 
the cells were maintained at a “progenitor” state and did not appear to continue to differentiate 
until they were removed from the feeder and exposed to hepatocyte differentiation conditions. 
By contrast, in our study, the bulk of the starting population was expanded and differentiated 
simultaneously, mimicking embryonic liver development in which hepatic endoderm and early 
hepatoblast differentiation occurs while the size of the liver is rapidly increasing. 
 
In spite of the increased expression of a number of hepatic genes, both D20-HLCs and EN2-
HLCs are not yet mature hepatocytes as transcript levels of enzymes involved in xenobiotic 
biotransformation are significantly lower in HLCs than in neonatal or adult hepatocytes (Data 
not shown).  In addition, the degree of cell expansion achieved in this study is still limited. For 
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potential applications in the future, a substantially larger level of expansion will still be more 
desirable. Further improvement of the protocol for hepatocyte differentiation from pluripotent 
stem cells is necessary to extend cell expansion and to achieve maturity of HLCs. However, our 
findings indicate that it is possible to expand endodermal cells during hepatocyte differentiation, 
which might alleviate the time and effort in generating large quantities of HLCs.  
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Figure Legends 
 
 
Figure 1. Protocol for expansion of hepatic endodermal cells.  
(a) Four stage directed hepatic differentiation protocol and the modified protocol 
with cell expansion in Stage 2. For expansion, cells at the endodermal stage (D6) were 
subcultured for 3 days (EN1) and subcultured again for another 3 day (EN2) in Stage 2 
medium. The expanded hepatic endodermal cells (EN2) were then continued to be 
cultured in Stage 3 and Stage 4 medium to become EN2-HLC. The cells derived with 
the conventional protocol are denoted as D20-HLC. 
(b) Increasing cell number during the course of cell expansion and regular 
differentiation. All error bars are represented as SD. (n=4) 
 
 Page 29 of 64 
St
em
 C
el
ls 
an
d 
D
ev
el
op
m
en
t
Ce
ll 
Ex
pa
ns
io
n 
D
ur
in
g 
D
ire
ct
ed
 D
iff
er
en
tia
tio
n 
O
f S
te
m
 C
el
ls 
To
w
ar
d 
Th
e 
H
ep
at
ic
 L
in
ea
ge
 (d
oi:
 10
.10
89
/sc
d.2
01
6.0
11
9)
Th
is 
ar
tic
le
 h
as
 b
ee
n 
pe
er
-re
vi
ew
ed
 a
nd
 a
cc
ep
te
d 
fo
r p
ub
lic
at
io
n,
 b
ut
 h
as
 y
et
 to
 u
nd
er
go
 c
op
ye
di
tin
g 
an
d 
pr
oo
f c
or
re
ct
io
n.
 T
he
 fi
na
l p
ub
lis
he
d 
ve
rs
io
n 
m
ay
 d
iff
er
 fr
om
 th
is 
pr
oo
f.
30 
30 
 
S
te
m
 C
el
ls
 a
n
d
 D
ev
el
o
p
m
en
t 
C
el
l 
E
x
p
an
si
o
n
 D
u
ri
n
g
 D
ir
ec
te
d
 D
if
fe
re
n
ti
at
io
n
 O
f 
S
te
m
 C
el
ls
 T
o
w
ar
d
 T
h
e 
H
ep
at
ic
 L
in
ea
g
e
 (
d
o
i:
 1
0
.1
0
8
9
/s
cd
.2
0
1
6
.0
1
1
9
) 
T
h
is
 p
ap
er
 h
as
 b
ee
n
 p
ee
r-
re
v
ie
w
ed
 a
n
d
 a
cc
ep
te
d
 f
o
r 
p
u
b
li
ca
ti
o
n
, 
b
u
t 
h
as
 y
et
 t
o
 u
n
d
er
g
o
 c
o
p
y
ed
it
in
g
 a
n
d
 p
ro
o
f 
co
rr
ec
ti
o
n
. 
T
h
e 
fi
n
al
 p
u
b
li
sh
ed
 v
er
si
o
n
 m
ay
 d
if
fe
r 
fr
o
m
 t
h
is
 p
ro
o
f.
 
 
 
Figure 2. Phenotype of endodermal cells undergoing expansion.  
(a)  Transcript level of marker genes in endodermal cells and their subsequent 
expansion stage. During D6, endodermal markers were prominent (CXCR4, GSC) and 
pluripotent markers were still present (OCT4). During the original method of 
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differentiation (D10 and D14) and the corresponding expansion stages (EN1 and E2), 
expression of pluripotent and endoderm markers decreased while hepatic markers (AFP 
and ALB) began to increase. All error bars are represented as SD. (n=4) 
(b) Immunostaining of endodermal cells undergoing simultaneous differentiation 
and expansion. Endodermal markers (FOXA2 and SOX17) were expressed in D6 cells 
but decreased in EN1 and EN2 cells. AFP expression increased in EN1 and EN2 cells. 
Scale bar = 150 µm. 
(c) Immunostaining of D20-HLCs and EN2-HLCs showing albumin expression. 
Scale bar = 50µm. 
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Figure 3. SPADE analysis of mass cytometry data of cells differentiating 
toward HLCs. 
The mass cytometry data of cells at different differentiation stages were clustered 
into 75 nodes by SPADE analysis. SPADE results for D6, EN1, EN2, D14, D20-HLC, 
and EN2-HLC are shown. The color and the size of a node represent percentage of the 
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populations for the node in each sample. Subpopulations enclosed in A, B, and C are 
classified as endodermal cells, hepatic endoderm/hepatoblasts, and 
hepatoblasts/hepatocytes, respectively. The methods for the classification of these 
subpopulations are described in detail in Figure S6. The percentage of endodermal 
cells, hepatic endoderm/hepatoblasts, and hepatoblasts/hepatocytes for each 
population is shown.  
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Figure 4. Transcript level of hepatic markers in D20-HLCs and EN2-HLCs. 
(a) D20-HLCs and EN2-HLC both expressed transcripts of hepatocyte markers AFP, 
ALB, AAT and PEPCK. (b) Transcript level change of CYP2A6, CYP2C8 and CYP2C9 
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in D20-HLCs and EN2-HLCs after induction with rifampicin. p-values of Student’s t-test 
are shown. (c-d) Activities of albumin secretion and urea synthesis of D20-HLCs and 
EN2-HLCs. The standard deviations of three biological replica are shown. (e) Glycogen 
staining of D20-HLCs and EN2-HLCs.  
All error bars are represented as SD. (n=3) 
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Figure 5. Transcriptome analysis of differentiating and expanding cells.  
Cell samples at different differentiation stages from the conventional protocol 
(blue) and expanding protocol (red) align along the same PC space (PC1 vs. PC2). EN1 
and EN2 samples are in between D6 and D10 (the beginning and end of Stage 2 
differentiation of the conventional protocol). 
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Figure 6. Transcript levels of stage-specific markers. 
Dynamics of key (a) endoderm markers and (b) hepatoblast markers are similar 
in cells differentiated with the two different protocols (dashed = original method, solid = 
expansion method). 
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Supplementary Figures 
 
 
Figure S1. Morphology of endodermal cells expanding 
a) Immediately after plating and b) after three days in Stage 2 conditions 
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Figure S2. Immunohistochemistry of endodermal cells during 
differentiation. Immunostaining of endodermal cells undergoing the conventional 
method of differentiation. Endodermal markers (FOXA2 and SOX17) were expressed in 
D6 cells and continued to be increased through day 14 but SOX17 expression is 
drastically decreased by day 14. AFP expression increases gradually from day 6 to until 
day 14 where a majority of the cells are positive for AFP.  Scale bar = 150 µm. 
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Figure S3.  Mass cytometry analysis 
Mass cytometry data is represented as a three-dimensional scatter plot with color 
representing the fourth dimension. The axes show the expression of different markers 
FOXA2, SOX17, CXCR4, DLK1, and ALB and the color gradient of each dot show the 
expression of CD44. The negative control for the markers used was hESCs which 
shows low expression for hepatic markers (DLK1 and ALB). As the cells undergo 
endodermal expansion, the endodermal genes decrease and CD44 expression 
increases. The presence of CD44 has been shown to play an important role in HGF-
induced signaling by promoting autophosphorylation of the HGF receptor, c-MET [29]. 
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Thus, CD44 is typically used as a marker for a subpopulation of hepatic progenitor cells 
that have high growth potential in culture [30]. The protein levels of SOX17 and CXCR4, 
very low in ESC (Figure S4a-c), began to be co-expressed in a distinct population 
(Figure S4d). During the course of the endodermal expansion, a very large fraction of 
cells co-expressing SOX17 and CXCR4 started to express CD44 (Figure S4d-f). 
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Figure S4.  Mass cytometry analysis 
Mass cytometry data is represented as a three-dimensional scatter plot with color 
representing the fourth dimension. The axes show the expression of different hepatic 
and endoderm markers ALB, SOX17, CXCR4, or DLK1 and the colored dots show the 
expression of CD44. As the cells undergo endodermal expansion, the endodermal 
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genes decrease and CD44 expression increases. Evaluation of the expanding D6 
population illustrated that the bulk of the cell population expressing both ALB and CD44 
also simultaneously lose expression of the endodermal markers, SOX17 and CXCR4, in 
line with results from qRT-PCR and immunostaining (Figure 2). DLK1 has frequently 
been used as a marker for early hepatocyte committed progenitor cells that can be 
isolated from the embryonic liver in vivo [31, 32]. Using DLK1 as a marker for 
hepatocyte-committed cells, a large fraction of the expanding EN1 and EN2 population 
began to gain DLK1 expression giving credence to the assignment of early hepatic 
subpopulation. The expression of CD44 and ALB were gradually increasing along with 
DLK1, showing co-expression of all three hepatoblast markers in the majority of DLK1 
positive cells. The co-expression of hepatoblast markers observed in the D20-HLCs and 
EN2-HLCs populations further illustrates that the majority of the cells are capable of 
differentiating towards the hepatocyte lineage regardless of whether or not they were 
subjected to endodermal expansion steps (Figure S5g and S5h). Notably both D20-
HLCs and EN2-HLCs showed low expression levels of CXCR4. 
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Figure S5. SPADE analysis of Mass cytometry data.  
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(a-h) The expression level of each of 8 markers is shown in a separate tree 
diagram. The color represents arcsinh transformed intensity of each marker. Median of 
the intensity for a node is shown. The expression level of each marker is ranked as high 
(++), moderate (+), and low (-). The threshold for ++ and + is 100 and 20 for CXCR4, 
100 and 10 for FOXA2, 60 and 8 for SOX17, 100 and 15 for CD44, 150 and 40 for ALB, 
100 and 14 for AAT, 150 and 30 for DLK1, and 100 and 20 for AFP, respectively. 
Unannotated parts of the SPADE tree for each marker were considered as the cells with 
low (-) expression of the marker.  The nodes enclosed in A, B, and C are classified as 
endodermal cells, hepatic endoderm/hepatoblasts, and hepatoblasts/hepatocytes, 
respectively. The following expression patterns were used to classify the 
subpopulations: (A) (CXCR4++/+   FOXA2++/+   SOX17++/+)   DLK1-   AFP-   ALB1-   
AAT- (“++/+” denotes ranging from ++ to +, and “ ” and “ ” represent union and 
intersection, respectively). (B) encompasses three subclasses: (i) (CXCR4++/+   
FOXA2++/+   SOX17++/+)   (DLK1++/+   AFP++/+   ALB++/+   AAT++/+), (ii) CXCR4++/+/-   
FOXA2++/+/-   SOX17++/+/-   (DLK1++/+   AFP++/+)   ALB+/-   AAT+/-, or (iii) CXCR4++/+/-   
FOXA2++/+/-   SOX17++/+/-   DLK1++/+/-   AFP++/+/-   (ALB+   AAT+). (C) CXCR4-   
FOXA2-   SOX17-   DLK1++/+/-   AFP++/+/-   ALB++   AAT++. i) K-means clustering was 
performed to the 75 nodes from the SPADE analysis based on the median intensity of 
the 8 markers (green lines: nodes in subpopulation A (endodermal cells), blue lines: 
nodes in subpopulation B (hepatic endoderm/hepatoblasts), red lines: nodes in 
subpopulation C (hepatoblasts/hepatocytes), and black lines: nodes not classified as 
any subpopulation). The distance was measured with Euclidean distance. 10 of the 14 
nodes in the A subpopulation were in Cluster 1. 11 of the 16 nodes in the C 
subpopulation were in Cluster 4, revealing that majority of the nodes in A and C were 
separately clustered. The majority of the B nodes were intersperse into Clusters 2 and 
3, with 12 and 10 of the B nodes in Clusters 2 and 3, respectively.  
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Figure S6. Mass cytometry and immunostaining of hepatic and endodermal 
markers. a) Immunostaining for AFP (white) and ALB (grey) was carried out at different 
stages of the differentiation along with the percentage of cells positive for AFP (white 
with lines) and ALB (grey with lines) found during mass cytometry. b)  Immunostaining 
for FOXA2 (white) and SOX17 (grey) was carried out at different stages of the 
differentiation along with the percentage of cells positive for FOXA2 (white with lines) 
and SOX17 (grey with lines) found during mass cytometry. c) Co-staining was carried 
out for FOXA2 (white) and SOX17 (grey) where the percentages of double positive 
(dark grey) cells were quantified and also compared to mass cytometry percentages 
(stripe bars). d) Co-staining was carried out for AFP (white) and ALB (grey) where the 
percentages of double positive (dark grey) cells were quantified and also compared to 
mass cytometry percentages (stripe bars). 
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Figure S7. Transcript dynamics of embryonic stem cell specific genes 
during directed differentiation with the original protocol or with simultaneous 
expansion.  
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Figure S8a-o. Transcript dynamics of embryonic liver specific genes during 
directed differentiation with the original protocol or with simultaneous expansion. 
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Figure S9. Comparison of transcript levels of genes of different functional 
classes between D20-HLC and EN2-HLC.  
(a) Expression levels of glycolysis/gluconeogenesis genes were similar between 
D20-HLCs and EN2-HLCs.  
(b) Expression levels of urea cycle genes were similar between D20-HLCs and 
EN2-HLCs.  
(c) Expression levels of fatty acid metabolism genes were similar between D20-
HLCs and EN2-HLCs.  
(d) Expression levels of genes in the cytochrome p450 family were similar 
between D20-HLCs and EN2-HLCs.  
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b
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 d
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o
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h
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o
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